Hosted on MSN1d
Siemens Healthineers and Cubresa sign agreement for BrainPET
Our company has built a foundation on delivering innovative, high-quality PET scanners to our customers worldwide, and the ...
Positron (OTCMKTS:POSC) Shares Down 6.2% – What’s Next?
Positron Co. (OTCMKTS:POSC – Get Free Report) shares fell 6.2% during mid-day trading on Friday . The company traded as low as $1.78 and last traded at $1.81. 34,998 shares traded hands during trading ...
Hosted on MSN6h
Artera partners with Tempus to expand AI cancer test access
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
PharmiWeb8d
Positron Emission Tomography (PET) Scanners Market…
Scanners IndustryThe global positron emission tomography (PET) scanners market is set to experience significant growth, with an estimated valuation of USD 1.3 billion in 2023 and a projected increase ...
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...
BioSpace3d
Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...
Business Insider16d
Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners
POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to ...
Radiopharm announces publication of clinical trial data highlighting RAD 101
Radiopharm Theranostic (RADX)s announced the publication of a novel imaging approach demonstrating proof-of-concept for the use of RAD 101 for ...